Your browser doesn't support javascript.
loading
Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses.
Proskorovsky, Irina; Benedict, Agnes; Negrier, Sylvie; Bargo, Danielle; Sandin, Rickard; Ramaswamy, Krishnan; Desai, Jigar; Cappelleri, Joseph C; Larkin, James.
Afiliação
  • Proskorovsky I; Evidera, 7575 Trans-Canada Highway, Suite 404, Montreal, Quebec, H4R 1V6, Canada. irina.proskorovsky@evidera.com.
  • Benedict A; Evidera, Budapest, Hungary.
  • Negrier S; University of Lyon, Centre Léon Bérard, Lyon, France.
  • Bargo D; Pfizer Inc, New York, NY, USA.
  • Sandin R; Pfizer AB, Vetenskapsvägen 10, 191 90, Sollentuna, Sweden.
  • Ramaswamy K; Pfizer Inc, New York, NY, USA.
  • Desai J; Pfizer Inc, New York, NY, USA.
  • Cappelleri JC; Pfizer Inc, New York, NY, USA.
  • Larkin J; Royal Marsden NHS Foundation Trust, London, UK.
BMC Cancer ; 18(1): 1271, 2018 Dec 19.
Article em En | MEDLINE | ID: mdl-30567533

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Carcinoma de Células Renais / Everolimo / Axitinibe / Anilidas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piridinas / Carcinoma de Células Renais / Everolimo / Axitinibe / Anilidas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article